Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$555M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$435M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$428M |
| 4 |
Accenture
ACN
|
+$402M |
| 5 |
Fortive
FTV
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$535M |
| 2 |
NVIDIA
NVDA
|
+$518M |
| 3 |
Coca-Cola
KO
|
+$488M |
| 4 |
AT&T
T
|
+$474M |
| 5 |
Meta Platforms (Facebook)
META
|
+$461M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.72% |
| 2 | Healthcare | 2.38% |
| 3 | Financials | 2.3% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CALL
Vanguard Health Care ETF
VHT
$18.7B
| $5.88M | ﹤0.01% |
23,100
+9,900
| +75% | +$2.45M |
|
3752
Codexis
CDXS
$158M
| $5.87M | ﹤0.01% |
284,812
-514,885
| -64% | -$10.7M |
|
|
GSQD
3753
DELISTED
G Squared Ascend I Inc.
GSQD
| $5.87M | ﹤0.01% |
596,088
-764,745
| -56% | -$7.55M |
|
3754
PUT
Genco Shipping & Trading
GNK
$1.1B
| $5.87M | ﹤0.01% |
248,500
+38,100
| +18% | +$705K |
|
|
PDOT
3755
DELISTED
Peridot Acquisition Corp. II
PDOT
| $5.87M | ﹤0.01% |
600,000
-3,129
| -0.5% | -$30.4K |
|
3756
PUT
Clover Health Investments
CLOV
$2.51B
| $5.86M | ﹤0.01% |
1,651,700
+1,141,000
| +223% | +$3.31M |
|
3757
PUT
Eastman Chemical
EMN
$8.42B
| $5.86M | ﹤0.01% |
52,300
-4,400
| -8% | -$516K |
|
|
SAVE
3758
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $5.86M | ﹤0.01% |
268,000
-222,600
| -45% | -$5.09M |
|
3759
CALL
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $5.85M | ﹤0.01% |
114,300
+97,500
| +580% | +$5M |
|
3760
CVR Energy
CVI
$3.13B
| $5.84M | ﹤0.01% |
228,775
-113,641
| -33% | -$2.36M |
|
|
RPT
3761
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $5.84M | ﹤0.01% |
424,374
+178,880
| +73% | +$2.34M |
|
3762
Conduent
CNDT
$264M
| $5.83M | ﹤0.01% |
1,130,554
+946,781
| +515% | +$4.66M |
|
3763
Madrigal Pharmaceuticals
MDGL
$11.8B
| $5.83M | ﹤0.01% |
59,452
-2,049
| -3% | -$173K |
|
3764
PUT
Cal-Maine
CALM
$3.99B
| $5.83M | ﹤0.01% |
105,600
+76,900
| +268% | +$3.35M |
|
|
AVLR
3765
PUT
DELISTED
Avalara, Inc.
AVLR
| $5.83M | ﹤0.01% |
58,600
-16,700
| -22% | -$1.69M |
|
3766
PUT
Concentrix
CNXC
$1.57B
| $5.83M | ﹤0.01% |
35,000
+23,700
| +210% | +$4.5M |
|
3767
CALL
Itaú Unibanco
ITUB
$87.5B
| $5.83M | ﹤0.01% |
1,156,453
-886,913
| -43% | -$3.74M |
|
|
NRAC
3768
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
| $5.82M | ﹤0.01% |
594,117
-1,593
| -0.3% | -$15.5K |
|
|
ATAQ
3769
DELISTED
Altimar Acquisition Corp III
ATAQ
| $5.82M | ﹤0.01% |
594,756
-6,424
| -1% | -$62.6K |
|
|
WIRE
3770
PUT
DELISTED
Encore Wire Corp
WIRE
| $5.82M | ﹤0.01% |
51,000
-16,400
| -24% | -$1.97M |
|
3771
CALL
Global E Online
GLBE
$7.11B
| $5.82M | ﹤0.01% |
172,200
-7,100
| -4% | -$268K |
|
|
CVAC
3772
DELISTED
CureVac
CVAC
| $5.82M | ﹤0.01% |
296,600
+279,368
| +1,621% | +$5.58M |
|
3773
Invesco NASDAQ 100 ETF
QQQM
$102B
| $5.82M | ﹤0.01% |
39,044
+23,145
| +146% | +$3.38M |
|
|
DALS
3774
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $5.81M | ﹤0.01% |
595,941
+2
| +0% | +$19 |
|
3775
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$199M
| $5.8M | ﹤0.01% |
398,942
+329,480
| +474% | +$4.91M |
|
Similar funds
Citadel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.
- Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
- Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
- Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
- Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
- Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
- Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.